Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

Clinical trial NCT00430521 · COMPLETED

Trial details

NCT number: NCT00430521
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Influenza Vaccines

Start date: 2007-02-05
Primary completion: 2008-10-20
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.